Filyn Inc

Filyn Inc. is reinventing regulatory science by bringing FDA submissions into the age of intelligent systems. The traditional regulatory process was built for typewriters and manual workflows; we’re building a new standard powered by AI. Our platform is designed to automate, audit, and intelligently generate regulatory submissions, starting with IND (Investigational New Drug) applications and expanding to NDA (New Drug Application) and BLA (Biologics License Application). Rather than simply digitizing old processes, Filyn embeds compliance logic and structured intelligence at the core of submission creation and review. By combining deep regulatory expertise with advanced technology, Filyn is creating systems that ensure every submission is credible, auditable, and aligned with FDA expectations from the start. Our mission is to enable life sciences companies to bring therapies to patients faster while maintaining the highest standards of compliance. We are an early-stage, high-impact team of regulatory leaders, engineers, and data scientists passionate about building the next generation of compliance infrastructure for the pharmaceutical and biotech industries. At Filyn, we are not just modernizing submissions—we are reimagining the foundation of regulatory science for the future of drug development.